close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly And Co

Recent news which mentions Eli Lilly And Co

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all
Tags Weight management Companies Novo Nordisk A/S
From CNBC.com News
People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group says
Tags Surgical procedures Health care industry US: News
From CNBC.com News
As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge
Tags Business News Pfizer Inc Novo Nordisk A/S
From CNBC.com News
Stocks making the biggest premarket moves: Walgreens, Kellogg, Eli Lilly, Delta and more
Tags Kellogg Co Economy Business
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Microsoft Corp Markets Lordstown Motors Corp
From CNBC.com News
Eli Lilly experimental obesity drug helped patients lose up to 24% of their weight, study says
Tags Novo Nordisk A/S Companies Health care industry
From CNBC.com News
Novo Nordisk says high-dose experimental obesity pill leads to 15% weight loss
Tags Pfizer Inc Business News Diabetes
From CNBC.com News
Pfizer to end development of experimental obesity pill due to elevated liver enzymes
Tags Size and weight discrimination Breaking news Health care industry
From CNBC.com News
Nearly 50% of top tech executives across the economy say A.I. is now their biggest spend: CNBC survey
Tags Technology: Trends Fortinet Inc Eli Lilly and Co
From CNBC.com News
Stocks making the biggest moves midday: Overstock, Tesla, Accenture and more
Tags Morgan Stanley Eli Lilly and Co Anheuser/Busch Inbev SA
From CNBC.com News
Pharmaceutical trade group sues Biden administration over Medicare drug price negotiations
Tickers LAW LAWS
Tags Law Companies Laws
From CNBC.com News
CNBC Daily Open: Rethinking the rally
Tags Eli Lilly and Co World Markets Apple Inc
From CNBC.com News
Eli Lilly to acquire Dice Therapeutics for $2.4 billion in autoimmune treatment push
Tags Breaking news Health care industry US: News
From CNBC.com News
Stocks making the biggest premarket moves: Alibaba, Dice Therapeutics, Avis and more
Tags Breaking News: Markets Dice Therapeutics Inc Philip Morris International Inc
From CNBC.com News
Drugmakers aim to strike down Medicare drug-price negotiations at Supreme Court
Tags Bristol/Myers Squibb Co Health care industry Johnson & Johnson
From CNBC.com News
Cramer explains how four different camps of buyers see mixed messages in the Fed's rate strategy
Tags Investment strategy Stock markets Business
From CNBC.com News
Eli Lilly CEO says Medicare price negotiations could harm drug development
Tags Companies Business News Policy
From CNBC.com News
Cramer's Lightning Round:
Tags stocks Lam Research Corp Investment Strategy
From CNBC.com News
Cramer's Lightning Round:
Tags GSK plc S&P 500 Market Outlook
From CNBC.com News
Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
Tags Food and drink Mad Money ONEOK Inc
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags Policy Biotechnology Biotech and Pharmaceuticals
From CNBC.com News
With debt crisis looming, look to these names and sectors, Jim Cramer says
Tags Investing Eli Lilly and Co Stock markets
From CNBC.com News
Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge
Tags Health care industry Sanofi SA Politics
From CNBC.com News
FDA commissioner praises Eli Lilly Alzheimer's treatment results
Tags Coronavirus Business News U/S/ Economy
From CNBC.com News
Stocks making the biggest moves midday: CVS Health, Eli Lilly, Clorox, Yum and more
Tags Markets Wingstop Inc stocks
From CNBC.com News
Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
Tags Markets Starbucks Corp Western Alliance Bancorp
From CNBC.com News
Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial
Tags Breaking News: Business US: News Health & Science
From CNBC.com News
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
Tags Quest Diagnostics Inc Biogen Inc Health & Science
From CNBC.com News
Obesity drug industry could be worth $200 billion within the decade, says Barclays, as market valuations grow
Tags Pharmaceuticals Health Care Services Biotechnology
From CNBC.com News
Thursday's rally showed the power of stock picking, Jim Cramer says
Tags Markets Microsoft Corp stocks
From CNBC.com News
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today